Want to join the conversation?
Jim Suva from Citi asks about the separation costs; is majority of it going to hit in 2016 or would continue beyond the year. $XRX CFO Leslie Varon said the separation costs are dominated by both costs and outflows this year. There will be minimal cost and cash outflows that will be incurred in 2017.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?